CRPS can frustrate patients, physicians | Ohio funds research into opioid alternatives | Study: People would pay $56 to $145 daily to be pain free
August 9, 2017
News for the pain professional
SIGN UP ⋅   FORWARD
Pain Research News
CRPS can frustrate patients, physicians
Complex regional pain syndrome can be difficult to diagnose in the early stages, and frustrating for patients and physicians. Children tend to respond well to treatments, especially rehabilitation programs dedicated to chronic pain syndromes, but patients who do not respond to conventional treatments may experience cycles of pain and loss of function.
The Washington Post (tiered subscription model) (8/6) 
LinkedIn Twitter Facebook Google+ Email
Ohio funds research into opioid alternatives
The Ohio Third Frontier Commission will award some $7 million in grants for projects aimed at preventing prescription overdoses, treating addiction and creating alternatives to opioid pain medications.
Patch/Beachwood, Ohio (8/9),  The Columbus Dispatch (Ohio) (tiered subscription model) (8/9) 
LinkedIn Twitter Facebook Google+ Email
Other News
Learn In Demand Skills in Health Care
GW's clinical research, health care quality and regulatory affairs programs prepare you to become a leader, able to meet the evolving nature of health care.
Learn More
ADVERTISEMENT
Treatment News
Study links long-term opioid use to adverse outcomes in polyneuropathy
A study in JAMA Neurology found patients with polyneuropathy who received long-term opioid therapy had greater risks for adverse outcomes, such as depression, opioid dependence or overdose and other chemical dependence, compared with those who were treated for less than 90 days. The findings, based on data for 2,892 patients, also showed that patients who used opioids in the long term were more likely to need an assistive device, report pain, have functional limitations or report difficulty in performing daily activities or report being no longer employed.
Neurology Advisor (8/4) 
LinkedIn Twitter Facebook Google+ Email
Greater gabapentin, pregabalin use linked to opioid crisis
Significant increases in prescriptions for gabapentin and pregabalin suggest physicians are choosing them for a wider variety of pain than approved indications, in response to the opioid epidemic, according to a report in the New England Journal of Medicine. The authors said additional research is needed to better define the role these drugs play in pain management.
Physician's Briefing/HealthDay News (8/2) 
LinkedIn Twitter Facebook Google+ Email
Other News
Policy & Trends
No emergency declaration needed for opioid crisis, administration says
No emergency declaration needed for opioid crisis, administration says
(Pool/Getty Images)
HHS Secretary Tom Price said there is no need to declare the opioid abuse epidemic a national public health emergency, as recommended by the White House's opioid commission, because the administration already has the ability to take action to curb the crisis, although the idea was not taken off the table entirely. President Donald Trump said his administration will fight the opioid crisis by strengthening law enforcement and security along the southern border to prevent drugs from entering the US.
The Washington Post (tiered subscription model) (8/8),  The Hill (8/8),  Politico (8/8) 
LinkedIn Twitter Facebook Google+ Email
 
Federal opioid commission urges funding for PDMP data sharing
The US should fund data sharing among state-based prescription-drug monitoring databases as well as provide technical support for regional law enforcement's substance diversion efforts, according to an interim report from the President's Commission on Combating Drug Addiction and the Opioid Crisis. "In addition to sharing data between states and the federal government, the PDMP needs to be improved with regard to its ease of use, and inclusion of other data to assist prescribing doctors," the report said.
Healthcare Informatics online (8/2) 
LinkedIn Twitter Facebook Google+ Email
Other News
APS News
Call for 2018 board nominations!
Please submit your nominations for the 2018 Board of Directors and Nominating Committee. Nominees must be APS members and should demonstrate such leadership qualities as vision, strategic thinking, motivation, communication skills and a sense of mission and dedication to the Society, its members and the purposes we serve. The deadline to submit a nomination is Aug. 14. Learn more.
LinkedIn Twitter Facebook Google+ Email
Nominate your colleagues for an APS Award!
Each year, the American Pain Society presents seven prestigious awards at its annual meeting. Now is your opportunity to recognize a colleague and nominate them for an award! The deadline for nominations is Aug. 28. Learn more.
LinkedIn Twitter Facebook Google+ Email
  
  
It is a fool's prerogative to utter truths that no one else will speak.
Neil Gaiman,
writer
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about APS:
Membership | Annual Meeting | Education
Funding Opportunities | About Us
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information